Chronic granulomatous disease is an inherited abnormality of certain cells of the immune system. These cells have difficulty forming the reactive oxygen compounds used to kill bacteria. Chronic granulomatous disease causes repeated bacterial infections, and without treatment, the disease can be fatal.
The nitroblue-tetrazolium (NBT) test is the most widely known test. Please consult a physician for more information about the test and other options that are available.
The following drug is FDA-approved for the treatment of CGD.